A novel EML4-ALK BIRC6-ALK double fusion variant in lung adenocarcinoma confers sensitivity to alectinib. (July 2020) - Zhong, Jiang-Ming; Zhang, Gui-Feng; Lin, Li; Li, De-Yu; Liu, Zhen-Hua